Prices delayed by at least 15 minutes | Print
DexCom (DXCM)
Common SharesThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
Address
6340 Sequence Drive
San Diego
CA
USA
92121
Telephone
+1 858 2000200
Forecast key dates
Name | Key Date |
---|---|
DexCom Inc First Quarter Earnings Conference Call for 2025 | 2025-04-25T16:30:00 |
DexCom Inc First Quarter Earnings Results for 2025 | 2025-04-25T00:00:00 |
DexCom Inc Fourth Quarter Earnings Conference Call for 2024 | 2025-02-07T16:30:00 |
DexCom Inc Annual Report for 2024 | 2025-02-07T00:00:00 |
DexCom Inc Fourth Quarter Earnings Results for 2024 | 2025-02-07T00:00:00 |
DexCom Inc Third Quarter Earnings Conference Call for 2024 | 2024-10-25T16:30:00 |
DexCom Inc Third Quarter Earnings Results for 2024 | 2024-10-25T00:00:00 |
DexCom Inc Second Quarter Earnings Conference Call for 2024 | 2024-07-26T16:30:00 |
DexCom Inc Second Quarter Earnings Results for 2024 | 2024-07-26T00:00:00 |
DexCom Inc Annual General Meeting for 2024 | 2024-05-17T14:00:00 |
Previous key dates
Name | Key Date |
---|---|
DexCom Inc Annual General Meeting for 2024 | 2024-05-17T14:00:00 |
DexCom Inc First Quarter Earnings Conference Call for 2024 | 2024-04-25T16:30:00 |
DexCom Inc First Quarter Earnings Result for 2024 | 2024-04-25T00:00:00 |
Dexcom 45th Annual Raymond James Institutional Investors Conference | 2024-03-05T08:40:00 |
DexCom Inc Fourth Quarter Earnings Conference Call for 2023 | 2024-02-08T16:30:00 |
DexCom Inc Annual Report for 2023 | 2024-02-08T00:00:00 |
DexCom Inc Fourth Quarter Earnings Result for 2023 | 2024-02-08T00:00:00 |
DexCom Inc Third Quarter Earnings Conference Call for 2023 | 2023-10-26T16:30:00 |
DexCom Inc Third Quarter Earnings Result for 2023 | 2023-10-26T00:00:00 |
DexCom Inc Second Quarter Earnings Conference Call for 2023 | 2023-07-27T16:30:00 |
DexCom Inc Second Quarter Earnings Result for 2023 | 2023-07-27T00:00:00 |
DexCom Inc Annual General Meeting for 2023 | 2023-05-18T14:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.